We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNET
2176
VNET Group
VNET
$2.14B
| $838K | 0.01% |
143,655
+118,898
| +480% | +$913K |
|
2177
Gossamer Bio
GOSS
$88.9M
| $836K | 0.01% |
96,262
+39,304
| +69% | +$379K |
|
2178
Midland States Bancorp
MSBI
$692M
| $836K | 0.01% |
28,961
-5,932
| -17% | -$170K |
|
2179
Nurix Therapeutics
NRIX
$2.69B
| $835K | 0.01% |
59,581
+44,567
| +297% | +$791K |
|
2180
STMicroelectronics
STM
$49.1B
| $835K | 0.01% |
19,330
-64,573
| -77% | -$2.85M |
|
|
ADRT.U
2181
DELISTED
Ault Disruptive Technologies Corporation Units, each consisting of one share of Common Stock, and three-fourths of one Redeemable Warrant to purchase one share of Common Stock
ADRT.U
| $835K | 0.01% |
82,817
-17,183
| -17% | -$173K |
|
|
AGS
2182
DELISTED
PlayAGS
AGS
| $831K | 0.01% |
124,567
+74,432
| +148% | +$559K |
|
2183
Nuvation Bio
NUVB
$2.24B
| $830K | 0.01% |
157,853
+107,262
| +212% | +$603K |
|
2184
Pacira BioSciences
PCRX
$972M
| $830K | 0.01% |
10,871
-51,798
| -83% | -$3.45M |
|
2185
Itaú Unibanco
ITUB
$82.7B
| $827K | 0.01% |
164,137
+66,472
| +68% | +$280K |
|
|
CVSA
2186
Covista Inc
CVSA
$4.31B
| $826K | 0.01% |
+27,792
| New | +$747K |
|
2187
JELD-WEN Holding
JELD
$164M
| $826K | 0.01% |
40,747
-104,700
| -72% | -$2.47M |
|
2188
Nerdy
NRDY
$95M
| $826K | 0.01% |
162,283
-98,875
| -38% | -$441K |
|
|
MIC
2189
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $826K | 0.01% |
221,368
-134,857
| -38% | -$493K |
|
|
YELL
2190
DELISTED
Yellow Corporation Common Stock
YELL
| $824K | 0.01% |
117,568
+36,261
| +45% | +$346K |
|
2191
Eagle Bancorp
EGBN
$865M
| $822K | 0.01% |
14,419
-30,861
| -68% | -$1.84M |
|
2192
Tanger
SKT
$4.43B
| $821K | 0.01% |
47,760
-100,186
| -68% | -$1.74M |
|
|
AVTA
2193
DELISTED
Avantax, Inc. Common Stock
AVTA
| $821K | 0.01% |
41,987
+11,366
| +37% | +$206K |
|
2194
Banco Bradesco
BBD
$35B
| $820K | 0.01% |
194,361
+8,535
| +5% | +$31.3K |
|
|
PING
2195
DELISTED
Ping Identity Holding Corp.
PING
| $820K | 0.01% |
29,878
-43,841
| -59% | -$921K |
|
2196
FB Financial Corp
FBK
$3.07B
| $819K | 0.01% |
18,442
-38,154
| -67% | -$1.7M |
|
2197
Archrock
AROC
$5.78B
| $817K | 0.01% |
88,511
+77,330
| +692% | +$662K |
|
|
CCXI
2198
DELISTED
ChemoCentryx, Inc.
CCXI
| $816K | 0.01% |
32,540
-5,958
| -15% | -$167K |
|
2199
Caesars Entertainment
CZR
$6.06B
| $815K | 0.01% |
10,532
-6,242
| -37% | -$501K |
|
2200
Hertz
HTZ
$873M
| $815K | 0.01% |
36,797
-355,115
| -91% | -$7.46M |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.